Month: March 2021

Gennao Bio Announces Abstract Accepted for Late-Breaker Poster Presentation at the American Association for Cancer Research (AACR) 2021 Annual Meeting

~ Presentation to highlight the potential of Gennao’s proprietary, non-viral gene monoclonal antibody (GMAB) platform technology to systemically deliver immunostimulatory...

Rubius Therapeutics to Present Initial Clinical Results from the Ongoing Phase 1/2 Clinical Trial of RTX-240 in Advanced Solid Tumors at the American Association of Cancer Research Virtual Annual Meeting

CAMBRIDGE, Mass., March 10, 2021 (GLOBE NEWSWIRE) -- Rubius Therapeutics, Inc. (Nasdaq:RUBY), a clinical-stage biopharmaceutical company that is genetically engineering...

GigCapital2 Announces Stockholder Approval of Extension Amendment to Complete its Business Combinations with UpHealth Holdings, Inc. and Cloudbreak Health, LLC

PALO ALTO, Calif.--(BUSINESS WIRE)--GigCapital2, Inc. (“GigCapital2”) (NYSE: GIX), a Technology, Media and Telecom (TMT) Private-to-Public Equity (PPE)™ corporation, today announced...

GigCapital2 Announces Stockholder Approval of Extension Amendment to Complete its Business Combinations with UpHealth Holdings, Inc. and Cloudbreak Health, LLC

PALO ALTO, Calif.--(BUSINESS WIRE)--GigCapital2, Inc. (“GigCapital2”) (NYSE: GIX), a Technology, Media and Telecom (TMT) Private-to-Public Equity (PPE)™ corporation, today announced...

error: Content is protected !!